ChIVPP/EVA hybrid chemotherapy for previously untreated Hodgkin's disease (HD): A highly effective etoposide containing regimen with a low incidence of secondary AML/MDS. Updated results from consecutive randomised clinical trials involving 701 patients

JA Radford, AZS Rohatiner, WDJ Ryder, DPD Deakin, T Barbui, NP Lucie, A Rossi, DJ Dunlop, RA Cowan, RK Gupta, RD James, J Shamash, J Chang, D Crowther, TA Lister

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageUndefined
Pages (from-to)61-61
Number of pages1
JournalBritish Journal of Cancer
Issue numberSupplement 1
Publication statusPublished - Jul 2001

Cite this